Phoenix Biotech Acquisition Corp.
NASDAQ:PBAX
5.85 (USD) • At close February 14, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2022 | 2021 | |
|---|---|---|
| Operating Activities: | ||
| Net Income
| -0.668 | -0.316 |
| Depreciation & Amortization
| 0 | 0 |
| Deferred Income Tax
| 0 | 0 |
| Stock Based Compensation
| 0 | 0 |
| Change In Working Capital
| 2.412 | -0.365 |
| Accounts Receivables
| 0 | 0 |
| Inventory
| 0 | 0 |
| Accounts Payables
| 1.639 | 0 |
| Other Working Capital
| 0.774 | -0.365 |
| Other Non Cash Items
| -2.837 | -0.016 |
| Operating Cash Flow
| -1.092 | -0.697 |
| Investing Activities: | ||
| Investments In Property Plant And Equipment
| 0 | 0 |
| Acquisitions Net
| 0 | 0 |
| Purchases Of Investments
| -0.325 | -178.5 |
| Sales Maturities Of Investments
| 0 | 0 |
| Other Investing Activites
| 181.164 | 0 |
| Investing Cash Flow
| 180.839 | -178.5 |
| Financing Activities: | ||
| Debt Repayment
| 0 | 0 |
| Common Stock Issued
| 0 | 180.296 |
| Common Stock Repurchased
| -139.354 | 0 |
| Dividends Paid
| 0 | 0 |
| Other Financing Activities
| -138.704 | 180.296 |
| Financing Cash Flow
| -138.704 | 180.296 |
| Other Information: | ||
| Effect Of Forex Changes On Cash
| 0 | 0 |
| Net Change In Cash
| 41.043 | 1.099 |
| Cash At End Of Period
| 42.142 | 1.099 |